Briana N Sprague1, Andrea L Rosso1, Xiaonan Zhu1, Nicolaas I Bohnen2,3, Caterina Rosano1. 1. Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. 2. Department of Radiology and Neurology, University of Michigan, Ann Arbor, Michigan, USA. 3. Ann Arbor VAMC, Ann Arbor, Michigan, USA.
Abstract
IMPORTANCE: Adapting one's gait speed to external circumstances is critical for safe ambulation. Dopamine (DA), critical for adapting to increased task demands, predicts usual gait speed and may exert a greater role in complex tasks like rapid gait speed. OBJECTIVE: We hypothesized that a genotypic proxy indicator of greater prefrontal DA signaling would predict significantly faster rapid gait. DESIGN: Longitudinal cohort study over 8 years. SETTING: Community-dwelling adults with no baseline mobility disability. PARTICIPANTS: N = 2353 participants from the Health ABC Study. MEASUREMENTS: Repeated measures of walking speed (meters/sec) were obtained in response to: "walk as fast as possible… (rapid gait) or "walk at your usual pace (usual gait)." Catechol-O-methyltransferase (COMT) val158met polymorphism indicated DA signaling (val/val = higher metabolism, lower DA signaling; met/met = lower metabolism, higher DA signaling). RESULTS: Participants declined in rapid gait from 1.55 (SD = 0.33) to 1.35 m/s (SD = 0.34). Across the full follow-up period, the met/met genotype was associated with significantly greater rapid gait slowing. In mixed effect models, between-group differences were independent of covariates, and remained similar after adjustment for sensorimotor function, cognition, depressive symptoms, and energy. Follow-up analyses indicated the met/met genotype had a significantly faster rapid gait speed compared to the val/val genotype for the first 3 years (p < 0.01) but not years 4-8 (p > 0.05). CONCLUSION: Greater prefrontal DA measured with COMT polymorphism may facilitate short-term adaptation to rapid walking demands that are lost over time. Studies should examine whether these effects are long-term and the underlying mechanistic pathways.
IMPORTANCE: Adapting one's gait speed to external circumstances is critical for safe ambulation. Dopamine (DA), critical for adapting to increased task demands, predicts usual gait speed and may exert a greater role in complex tasks like rapid gait speed. OBJECTIVE: We hypothesized that a genotypic proxy indicator of greater prefrontal DA signaling would predict significantly faster rapid gait. DESIGN: Longitudinal cohort study over 8 years. SETTING: Community-dwelling adults with no baseline mobility disability. PARTICIPANTS: N = 2353 participants from the Health ABC Study. MEASUREMENTS: Repeated measures of walking speed (meters/sec) were obtained in response to: "walk as fast as possible… (rapid gait) or "walk at your usual pace (usual gait)." Catechol-O-methyltransferase (COMT) val158met polymorphism indicated DA signaling (val/val = higher metabolism, lower DA signaling; met/met = lower metabolism, higher DA signaling). RESULTS: Participants declined in rapid gait from 1.55 (SD = 0.33) to 1.35 m/s (SD = 0.34). Across the full follow-up period, the met/met genotype was associated with significantly greater rapid gait slowing. In mixed effect models, between-group differences were independent of covariates, and remained similar after adjustment for sensorimotor function, cognition, depressive symptoms, and energy. Follow-up analyses indicated the met/met genotype had a significantly faster rapid gait speed compared to the val/val genotype for the first 3 years (p < 0.01) but not years 4-8 (p > 0.05). CONCLUSION: Greater prefrontal DA measured with COMT polymorphism may facilitate short-term adaptation to rapid walking demands that are lost over time. Studies should examine whether these effects are long-term and the underlying mechanistic pathways.
Authors: Brittney S Lange-Maia; Anne B Newman; Elsa S Strotmeyer; Tamara B Harris; Paolo Caserotti; Nancy W Glynn Journal: Aging Clin Exp Res Date: 2014-11-06 Impact factor: 3.636
Authors: Jean-Claude Dreher; Philip Kohn; Bhaskar Kolachana; Daniel R Weinberger; Karen Faith Berman Journal: Proc Natl Acad Sci U S A Date: 2008-12-22 Impact factor: 11.205
Authors: Irina Baetu; Nicholas R Burns; Kristi Urry; Girolamo Giovanni Barbante; Julia B Pitcher Journal: Neurobiol Learn Mem Date: 2015-09-28 Impact factor: 2.877
Authors: Joaquin A Anguera; Patricia A Reuter-Lorenz; Daniel T Willingham; Rachael D Seidler Journal: J Cogn Neurosci Date: 2010-09 Impact factor: 3.225
Authors: Nandini Deshpande; E Jeffrey Metter; Stefania Bandinelli; Jack Guralnik; Luigi Ferrucci Journal: Age Ageing Date: 2009-06-23 Impact factor: 10.668
Authors: K Tiainen; S Pajala; S Sipilä; J Kaprio; M Koskenvuo; M Alén; E Heikkinen; A Tolvanen; T Rantanen Journal: Scand J Med Sci Sports Date: 2007-06 Impact factor: 4.221